Seguir
Agustín Lahoz
Agustín Lahoz
Instituto de Investigación Sanitaria Hospital La Fe
Dirección de correo verificada de uv.es
Título
Citado por
Citado por
Año
Cell lines: a tool for in vitro drug metabolism studies
MJ Gomez-Lechon, MT Donato, A Lahoz, JV Castell
Current drug metabolism 9 (1), 1-11, 2008
4052008
Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells
S Antherieu, C Chesne, R Li, S Camus, A Lahoz, L Picazo, M Turpeinen, ...
Drug Metabolism and Disposition 38 (3), 516-525, 2010
2852010
Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method
JC García-Cañaveras, MT Donato, JV Castell, A Lahoz
Journal of lipid research 53 (10), 2231-2241, 2012
2642012
Mammalian cell metabolomics: experimental design and sample preparation
Z León, JC García‐Cañaveras, MT Donato, A Lahoz
Electrophoresis 34 (19), 2762-2775, 2013
2162013
Unprecedented Blue Intrinsic Photoluminescence from Hyperbranched and Linear Polyethylenimines: Polymer Architectures and pH‐Effects
L Pastor‐Pérez, Y Chen, Z Shen, A Lahoz, SE Stiriba
Macromolecular rapid communications 28 (13), 1404-1409, 2007
1912007
A score model for the continuous grading of early allograft dysfunction severity
E Pareja, M Cortes, D Hervás, J Mir, A Valdivieso, JV Castell, A Lahoz
Liver Transplantation 21 (1), 38-46, 2015
1812015
Potential impact of steatosis on cytochrome P450 enzymes of human hepatocytes isolated from fatty liver grafts
MT Donato, A Lahoz, N Jimenez, G Pérez, A Serralta, J Mir, JV Castell, ...
Drug metabolism and disposition 34 (9), 1556-1562, 2006
1682006
A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations
JC García-Canaveras, MT Donato, JV Castell, A Lahoz
Journal of proteome research 10 (10), 4825-4834, 2011
1502011
Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs
L Tolosa, S Pinto, MT Donato, A Lahoz, JV Castell, JE O’Connor, ...
Toxicological Sciences 127 (1), 187-198, 2012
1382012
In vitro evaluation of potential hepatotoxicity induced by drugs
MJ Gomez-Lechon, A Lahoz, L Gombau, JV Castell, MT Donato
Current pharmaceutical design 16 (17), 1963-1977, 2010
1362010
A small molecule G6PD inhibitor reveals immune dependence on pentose phosphate pathway
JM Ghergurovich, JC García-Cañaveras, J Wang, E Schmidt, Z Zhang, ...
Nature chemical biology 16 (7), 731-739, 2020
1152020
Polypodium leucotomos extract: antioxidant activity and disposition
L Gombau, F García, A Lahoz, M Fabre, P Roda-Navarro, P Majano, ...
Toxicology in vitro 20 (4), 464-471, 2006
992006
Assessing the metabolic competence of sandwich-cultured mouse primary hepatocytes
K Mathijs, AS Kienhuis, KJJ Brauers, DGJ Jennen, A Lahoz, ...
Drug Metabolism and Disposition 37 (6), 1305-1311, 2009
902009
Validated assay for studying activity profiles of human liver UGTs after drug exposure: inhibition and induction studies
MT Donato, S Montero, JV Castell, MJ Gómez-Lechón, A Lahoz
Analytical and bioanalytical chemistry 396, 2251-2263, 2010
822010
Prediagnostic plasma bile acid levels and colon cancer risk: a prospective study
T Kühn, M Stepien, M López-Nogueroles, A Damms-Machado, ...
JNCI: Journal of the National Cancer Institute 112 (5), 516-524, 2020
812020
Metabolomics discloses donor liver biomarkers associated with early allograft dysfunction
M Cortes, E Pareja, JC García-Cañaveras, M Teresa Donato, S Montero, ...
Journal of Hepatology, 2014
782014
Human Embryonic Stem Cell Derived Hepatocyte-Like Cells as a Tool for In Vitro Hazard Assessment of Chemical Carcinogenicity
R Yildirimman, G Brolén, M Vilardell, G Eriksson, J Synnergren, ...
Toxicological Sciences 124 (2), 278-290, 2011
752011
A metabolomics cell-based approach for anticipating and investigating drug-induced liver injury
JC García-Cañaveras, JV Castell, MT Donato, A Lahoz
Scientific reports 6 (1), 27239, 2016
732016
Chemometric approaches to improve PLSDA model outcome for predicting human non-alcoholic fatty liver disease using UPLC-MS as a metabolic profiling tool
G Quintás, N Portillo, JC García-Cañaveras, JV Castell, A Ferrer, A Lahoz
Metabolomics 8, 86-98, 2012
732012
Interactions of polyphenols with the P450 system: possible implications on human therapeutics.
I Rodeiro, MT Donato, A Lahoz, G Garrido, R Delgado, MJ Gómez-Lechón
Mini reviews in medicinal chemistry 8 (2), 97-106, 2008
702008
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20